Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Reviva Pharmaceuticals Holdings Inc | RVPH | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.30 | 1.30 | 1.44 | 1.38 | 1.53 |
Recent News
Date | Time | Source | Heading |
---|---|---|---|
17/2/2024 | 08:32 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
14/2/2024 | 16:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
14/2/2024 | 09:00 | EDGAR2 | Form 424B4 - Prospectus [Rule 424(b)(4)] |
03/2/2024 | 08:38 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
18/11/2023 | 08:05 | EDGAR2 | Form 8-K - Current report |
18/11/2023 | 08:03 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
15/11/2023 | 08:12 | EDGAR2 | Form 8-K - Current report |
30/10/2023 | 23:20 | EDGAR2 | Form 8-K - Current report |
05/10/2023 | 08:03 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
05/10/2023 | 08:02 | EDGAR2 | Form 8-K - Current report |
17/8/2023 | 20:30 | EDGAR2 | Form 8-K - Current report |
15/8/2023 | 06:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
15/8/2023 | 06:15 | EDGAR2 | Form 8-K - Current report |
25/7/2023 | 06:16 | EDGAR2 | Form 8-K - Current report |